HOME › DRUGS › OLOPATADINE HYDROCHLORIDE
ACTIVE SUBSTANCE / INN

OLOPATADINE HYDROCHLORIDE

Brand name(s): PATADAY TWICE DAILY RELIEF, RYALTRIS, OLOPATADINE HYDROCHLORIDE, PATADAY ONCE DAILY RELIEF, PATANASE
FDA LISTED
PRESCRIPTION
OVER-THE-COUNTER
DISCONTINUED
ANDA203416
NDA020688
ACTIVE SUBSTANCE
Olopatadine Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, ALCON LABS INC, FLORIDA
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OLOPATADINE HYDROCHLORIDEANDA204392RISINGOver-the-counter
OLOPATADINE HYDROCHLORIDEANDA208637FLORIDADiscontinued
OLOPATADINE HYDROCHLORIDEANDA210901AMNEALPrescription
PATANASENDA021861NOVARTISDiscontinued
OLOPATADINE HYDROCHLORIDEANDA203416WATSON LABSNone (Tentative Approval)
RYALTRISNDA211746GLENMARK SPECLTPrescription
PATADAY ONCE DAILY RELIEFNDA206276ALCON LABS INCOver-the-counter
PATADAY TWICE DAILY RELIEFNDA020688ALCON LABS INCOver-the-counter

FULL INTELLIGENCE ON OLOPATADINE HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →